Is Kybella the Next Big Thing? One Surgeon Shares His Insights and Experience with Kybella
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Joe Niamtu III, DMD, shares his insights and experience with Kythera Biopharmaceuticals’ new fat-dissolving injectable Kybella in this August 2015 feature.
Incyte’s sNDA for ruxolitinib cream in children ages 2–11 now faces a new action date to allow additional data review.